• 1
    Caspi A, Moffitt TE, Cannon M et al. Moderation of the effect of adolescent-onset cannabis use on adult psychosis by a functional polymorphism in the catechol-o-methyltransferase gene: longitudinal evidence of a gene × environment interaction. Biol Psychiatry 2005;57:11171127.
  • 2
    Henquet C, Rosa A, Krabbendam L et al. An experimental study of catechol-o-methyltransferase val(158)met moderation of delta-9-tetrahydrocannabinol-induced effects on psychosis and cognition. Neuropsychopharmacology 2006;31:27482757.
  • 3
    Lachman HM, Papolos DF, Saito T, Yu YM, Szumlanski CL, Weinshilboum RM. Human catechol-o-methyltransferase pharmacogenetics: description of a functional polymorphism and its potential application to neuropsychiatric disorders. Pharmacogenetics 1996;6:243250.
  • 4
    Bilder RM, Volavka J, Lachman HM, Grace AA. The catechol-o-methyltransferase polymorphism: relations to the tonic-phasic dopamine hypothesis and neuropsychiatric phenotypes. Neuropsychopharmacology 2004;29:19431961.
  • 5
    Voruganti LN, Slomka P, Zabel P, Mattar A, Awad AG. Cannabis induced dopamine release: an in-vivo SPECT study. Psychiatry Res 2001;107:173177.
  • 6
    Zammit S, Spurlock G, Williams H et al. Genotype effects of CHRNA7, CNR1 and COMT in schizophrenia: interactions with tobacco and cannabis use. Br J Psychiatry 2007;191:402407.
  • 7
    Daniels JK, Williams NM, Williams J et al. No evidence for allelic association between schizophrenia and a polymorphism determining high or low catechol o-methyltransferase activity. Am J Psychiatry 1996;153:268270.
  • 8
    Myin-Germeys I, Krabbendam L, Jolles J, Delespaul PA, Van Os J. Are cognitive impairments associated with sensitivity to stress in schizophrenia? An experience sampling study. Am J Psychiatry 2002;159:443449.
  • 9
    Myin-Germeys I, Van Os J, Schwartz JE, Stone AA, Delespaul PA. Emotional reactivity to daily life stress in psychosis. Arch Gen Psychiatry 2001;58:11371144.
  • 10
    Van Winkel R, Henquet C, Rosa A et al. Evidence that the COMT(Val158Met) polymorphism moderates sensitivity to stress in psychosis: an experience-sampling study. Am J Med Genet B Neuropsychiatr Genet 2008;147:1017.
  • 11
    Delespaul PAEG. Assessing schizophrenia in daily life: the experience sampling method. Maastricht: University Press Maastricht, 1995.
  • 12
    Hanssen M, Bak M, Bijl R, Vollebergh W, Van Os J. The incidence and outcome of subclinical psychotic experiences in the general population. Br J Clin Psychol 2005;44:181191.
  • 13
    Clayton D, Hills M. Wald tests. In: ClaytonD, HillsM, eds. Statistical models in epidemiology. Oxford, New York: Oxford University Press, 1993:101102.
  • 14
    Verdoux H, Gindre C, Sorbara F, Tournier M, Swendsen JD. Effects of cannabis and psychosis vulnerability in daily life: an experience sampling test study. Psychol Med 2003;33:2332.
  • 15
    Henquet C, Murray R, Linszen D, Van Os J. The environment and schizophrenia: the role of cannabis use. Schizophr Bull 2005;31:608612.
  • 16
    Grace AA. The tonic/phasic model of dopamine system regulation and its implications for understanding alcohol and psychostimulant craving. Addiction 2000;95(suppl. 2):S119S128.
  • 17
    Kapur S. Psychosis as a state of aberrant salience: a framework linking biology, phenomenology, and pharmacology in schizophrenia. Am J Psychiatry 2003;160:1323.
  • 18
    Laruelle M. The role of endogenous sensitization in the pathophysiology of schizophrenia: implications from recent brain imaging studies. Brain Res Brain Res Rev 2000;31:371384.
  • 19
    Myin-Germeys I, Marcelis M, Krabbendam L, Delespaul P, Van Os J. Subtle fluctuations in psychotic phenomena as functional states of abnormal dopamine reactivity in individuals at risk. Biol Psychiatry 2005;58:105110.
  • 20
    Rosa A, Peralta V, Cuesta MJ et al. New evidence of association between COMT gene and prefrontal neurocognitive function in healthy individuals from sibling pairs discordant for psychosis. Am J Psychiatry 2004;161:11101112.
  • 21
    Bentall RP, Kinderman P, Kaney S. The self, attributional processes and abnormal beliefs: towards a model of persecutory delusions. Behav Res Ther 1994;32:331341.
  • 22
    Krabbendam L, Myin-Germeys I, Hanssen M et al. Hallucinatory experiences and onset of psychotic disorder: evidence that the risk is mediated by delusion formation. Acta Psychiatr Scand 2004;110:264272.
  • 23
    Jacobs N, Nicolson NA, Derom C, Delespaul P, Van Os J, Myin-Germeys I. Electronic monitoring of salivary cortisol sampling compliance in daily life. Life Sci 2005;76:24312443.